NEW YORK, Jan. 4 /PRNewswire/ -- IMPATH Inc. (Nasdaq: IMPH), announced
today that Dr. Anu D. Saad, Chairman and Chief Executive Officer of IMPATH is
scheduled to present the Company at the JPMorgan H&Q 20th Annual Healthcare
Conference at the Westin St. Francis Hotel in San Francisco, California. The
presentation on Thursday, January 10th at 10:30 AM (PST) will be webcast live
and may be accessed from http://www.jpmhq.com (conference webcast link).
Other conferences in which IMPATH will be appearing are detailed on the
investor relations page of http://www.impath.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010516/IMPHLOGO )
IMPATH is in the business of improving outcomes for cancer patients. The
Company is the leading source of cancer information and analyses with a
database of more than 800,000 analyzed cases to date. IMPATH uses
sophisticated technologies to provide patient-specific cancer diagnostic and
prognostic information to pathologists, oncologists and transplant centers.
IMPATH currently serves more than 7,850 physicians specializing in the
treatment of cancer patients, in over 1,975 hospitals and 445 oncology
practices. Utilizing its comprehensive resources, the IMPATH Predictive
Oncology division serves genomics, biotechnology and pharmaceutical companies
involved in developing new therapeutics targeted to specific, biological
characteristics of cancer.
SOURCE IMPATH Inc.
 back to top
Related links:
http://www.impath.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20010516/IMPHLOGO
CONTACT:
Iris D. Daniels, Vice President, Investor
Relations and Corporate Communications of IMPATH Inc.,
+1-212-698-0300
|
